Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 21 July, 2010 and appeared in  Issue 531

Disrupted Sleep Patterns Adds to Risk of Obesity, Diabetes

Disrupted sleep patterns seem to contribute to the risk of obesity and diabetes, according to numerous studies. Scientists have theorized that disrupted circadian rhythms throw off various hormonal processes in the body that contribute to disease....
Advertisement

Researchers at UT Southwestern Medical Center in Dallas have found that mice with defective copies of two genes involved in circadian rhythms develop abnormalities in their pancreatic cells that eventually cause problems with the release of insulin.

This theory is looking stronger all the time, and the mounting evidence bolsters the argument that people should care about their sleep habits and these should be discussed while educating every patient with diabetes.

One gene, the CLOCK gene, operates in many parts of the body to control circadian processes. The other gene, BMAL1, works with the CLOCK protein. In the study, scientists engineered some mice to have defective CLOCK genes in the pancreas and some to lack the BMAL1 gene.  

They found that mice with the mutant CLOCK gene were defective in releasing insulin. These mice were prone to obesity and other health problems related to liver and metabolic function. The mice lacking the BMAL1 gene in their pancreas had normal body weight and normal circadian patterns but had abnormal blood sugar levels. 

The study shows that disruption of these genes only in the pancreas causes early signs of diabetes.

"These results indicate that disruption of the daily clock may contribute to diabetes by impairing the pancreas' ability to deliver insulin," Dr. Joseph Takahashi, a co-author of the paper, stated in a news release.
journal Nature, July 09, 2010

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 21 July, 2010 and appeared in  Issue 531

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control